EMPLOYMENT TYPE MIX · DOL LCA DATA

Alexion Pharmaceuticals, Inc. H-1B New Employment

Of Alexion Pharmaceuticals, Inc.'s 130 certified H-1B filings with a stated employment type (FY2022–2026), 32.3% are new employment at a median of $125K/year. The rest are extensions, transfers and amendments for workers already sponsored.

32.3%
New Employment
42
New-Hire Filings
$125K
Median, New Hires
$152K
Median, Renewals

Is Alexion Pharmaceuticals, Inc. Hiring New H-1B Workers?

Yes. At 32.3%, Alexion Pharmaceuticals, Inc. files a high share of genuinely new H-1B employment, so a meaningful part of its sponsorship goes to people it has not sponsored before. That is the population an outside applicant joins.

Employment Type Breakdown at Alexion Pharmaceuticals, Inc.

New employmentA worker not already on H-1B with this employer, the route in from outside
42 filings · 32.3%
Continuation / extensionExtending an existing H-1B for someone already on staff
23 filings · 17.7%
Change of employerTaking on a worker who already holds H-1B elsewhere
31 filings · 23.8%
Amended petitionChanging the terms of an existing petition, such as a new work site
11 filings · 8.5%
Change at same employerA material change to the same worker's existing role
23 filings · 17.7%
Concurrent employmentA second, simultaneous H-1B alongside another employer
0 filings · 0%

Bars are scaled to this employer's largest category, not to 100%. Percentages are of Alexion Pharmaceuticals, Inc.'s 130 certified filings that state an employment type. A small number of filings tick more than one box, so the shares can total slightly above 100%.

Is That Share Rising or Falling?

FY2022
18.2% of 11
FY2023
8.3% of 12
FY2024
38.6% of 57
FY2025
33.3% of 48
FY2026
50% of 2

New-employment share per fiscal year, each against that year's filings with a stated type. Bars are scaled to this employer's peak year.

What Roles Is Alexion Pharmaceuticals, Inc. Hiring Into?

Job titles on Alexion Pharmaceuticals, Inc.'s new-employment filings specifically, which is what it is actually growing rather than merely maintaining.

RoleNew-Hire FilingsMedian Wage
Biochemists and Biophysicists13$123K
Biostatisticians5$143K
Medical Scientists, Except Epidemiologists4$115K
Molecular and Cellular Biologists4$122K
Market Research Analysts and Marketing Specialists3$175K
Bioengineers and Biomedical Engineers2$130K
Chemical Engineers2$88K
Compliance Managers2$107K

Why This Number Matters

Total sponsorship volume is the figure most job boards quote, and on its own it is misleading. An employer filing thousands of petitions a year can be filing almost all of them to extend people it sponsored years ago, which tells an outside applicant very little about their odds.

The new-employment share separates the two. It is the employer's own checkbox on the Labor Condition Application, not an estimate, and it identifies the filings that represent someone entering the company rather than staying in it.

More on Alexion Pharmaceuticals, Inc.

Related

Job Alert Pro

âš¡ Never miss an H1B job again

Get instant email alerts for new H1B jobs matching your skills, location, and seniority level. Our system scans 130+ companies daily and notifies you before jobs fill up.

  • ✓ Real-time job matching (alerts within minutes of posting)
  • ✓ Verified H1B sponsors only (100% sponsorship history verified)
  • ✓ Mobile app notifications (never miss a job)
  • ✓ Advanced filters (location, salary, seniority, role)
  • ✓ Cancel anytime (no long-term commitment)
$25/mo
Start Free Trial
HJ

H1B Visa Jobs Research Team

Counted from US Department of Labor LCA disclosure files (FY2022–2026) for certified petitions filed by Alexion Pharmaceuticals, Inc. with annual wages between $30K and $1M, combining 2 legal-name spellings DOL records for this employer. Shares are of the 130 filings that tick at least one employment-type box; the remaining 30.1% of Alexion Pharmaceuticals, Inc.'s 186 certified filings state no type and are excluded rather than counted as renewals. A certified LCA is a step toward an H-1B petition, not an approved visa.